Clinical Trial Update: Safety and Efficacy of Synthetic Human Secretin-Enhanced MRCP in Subjects With Abnormalities of the Pancreas [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the safety and efficacy of synthetic human secretin-enhanced MRCP in subjects with pancreatic abnormalities, with the study ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatitis

Drugs mentioned

• Synthetic human secretin-enhanced MRCP (secretin)

Snippet

Sponsor: Repligen Corporation | Conditions: Pancreatitis | Phase 3 | Status: COMPLETED